139 related articles for article (PubMed ID: 37102476)
1. Research Progress on the Effect of Autophagy and Exosomes on Liver Fibrosis.
Du Y; Zhu S; Zeng H; Wang Z; Huang Y; Zhou Y; Zhang W; Zhu J; Yang C
Curr Stem Cell Res Ther; 2024; 19(6):785-797. PubMed ID: 37102476
[TBL] [Abstract][Full Text] [Related]
2. Exosomes derived from miR-181-5p-modified adipose-derived mesenchymal stem cells prevent liver fibrosis via autophagy activation.
Qu Y; Zhang Q; Cai X; Li F; Ma Z; Xu M; Lu L
J Cell Mol Med; 2017 Oct; 21(10):2491-2502. PubMed ID: 28382720
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-30a ameliorates hepatic fibrosis by inhibiting Beclin1-mediated autophagy.
Chen J; Yu Y; Li S; Liu Y; Zhou S; Cao S; Yin J; Li G
J Cell Mol Med; 2017 Dec; 21(12):3679-3692. PubMed ID: 28766848
[TBL] [Abstract][Full Text] [Related]
4. Hepatic stellate cell autophagy inhibits extracellular vesicle release to attenuate liver fibrosis.
Gao J; Wei B; de Assuncao TM; Liu Z; Hu X; Ibrahim S; Cooper SA; Cao S; Shah VH; Kostallari E
J Hepatol; 2020 Nov; 73(5):1144-1154. PubMed ID: 32389810
[TBL] [Abstract][Full Text] [Related]
5. HepG2.2.15-derived exosomes facilitate the activation and fibrosis of hepatic stellate cells.
Gao Y; Li L; Zhang SN; Mang YY; Zhang XB; Feng SM
World J Gastroenterol; 2024 May; 30(19):2553-2563. PubMed ID: 38817658
[TBL] [Abstract][Full Text] [Related]
6. sEVs from tonsil-derived mesenchymal stromal cells alleviate activation of hepatic stellate cells and liver fibrosis through miR-486-5p.
Kim J; Lee C; Shin Y; Wang S; Han J; Kim M; Kim JM; Shin SC; Lee BJ; Kim TJ; Jung Y
Mol Ther; 2021 Apr; 29(4):1471-1486. PubMed ID: 33348053
[TBL] [Abstract][Full Text] [Related]
7. Mesenchymal stem cell-originated exosomal circDIDO1 suppresses hepatic stellate cell activation by miR-141-3p/PTEN/AKT pathway in human liver fibrosis.
Ma L; Wei J; Zeng Y; Liu J; Xiao E; Kang Y; Kang Y
Drug Deliv; 2022 Dec; 29(1):440-453. PubMed ID: 35099348
[TBL] [Abstract][Full Text] [Related]
8. MiR-122 modification enhances the therapeutic efficacy of adipose tissue-derived mesenchymal stem cells against liver fibrosis.
Lou G; Yang Y; Liu F; Ye B; Chen Z; Zheng M; Liu Y
J Cell Mol Med; 2017 Nov; 21(11):2963-2973. PubMed ID: 28544786
[TBL] [Abstract][Full Text] [Related]
9. Autophagy in hepatic progenitor cells modulates exosomal miRNAs to inhibit liver fibrosis in schistosomiasis.
Yuan Y; Li J; Lu X; Chen M; Liang H; Chen XP; Long X; Zhang B; Gong S; Huang X; Zhao J; Chen Q
Front Med; 2024 Jun; 18(3):538-557. PubMed ID: 38769281
[TBL] [Abstract][Full Text] [Related]
10. Recent advances in the role of exosomes in liver fibrosis.
Shen J; Cao J; Chen M; Zhang Y
J Gastroenterol Hepatol; 2023 Jul; 38(7):1083-1088. PubMed ID: 37114594
[TBL] [Abstract][Full Text] [Related]
11. Exosome-Mediated Intercellular Communication between Hepatitis C Virus-Infected Hepatocytes and Hepatic Stellate Cells.
Devhare PB; Sasaki R; Shrivastava S; Di Bisceglie AM; Ray R; Ray RB
J Virol; 2017 Mar; 91(6):. PubMed ID: 28077652
[TBL] [Abstract][Full Text] [Related]
12. Human induced pluripotent stem cell-derived extracellular vesicles reduce hepatic stellate cell activation and liver fibrosis.
Povero D; Pinatel EM; Leszczynska A; Goyal NP; Nishio T; Kim J; Kneiber D; de Araujo Horcel L; Eguchi A; Ordonez PM; Kisseleva T; Feldstein AE
JCI Insight; 2019 Jun; 5(14):. PubMed ID: 31184999
[TBL] [Abstract][Full Text] [Related]
13. Exosomal miR-103-3p from LPS-activated THP-1 macrophage contributes to the activation of hepatic stellate cells.
Chen L; Yao X; Yao H; Ji Q; Ding G; Liu X
FASEB J; 2020 Apr; 34(4):5178-5192. PubMed ID: 32061112
[TBL] [Abstract][Full Text] [Related]
14. Gα
Kim KM; Han CY; Kim JY; Cho SS; Kim YS; Koo JH; Lee JM; Lim SC; Kang KW; Kim JS; Hwang SJ; Ki SH; Kim SG
J Hepatol; 2018 Mar; 68(3):493-504. PubMed ID: 29080810
[TBL] [Abstract][Full Text] [Related]
15. Mesenchymal stem cell-derived exosomes protect against liver fibrosis via delivering miR-148a to target KLF6/STAT3 pathway in macrophages.
Tian S; Zhou X; Zhang M; Cui L; Li B; Liu Y; Su R; Sun K; Hu Y; Yang F; Xuan G; Ma S; Zheng X; Zhou X; Guo C; Shang Y; Wang J; Han Y
Stem Cell Res Ther; 2022 Jul; 13(1):330. PubMed ID: 35858897
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic role of FNDC5/irisin in attenuating liver fibrosis via inhibiting release of hepatic stellate cell-derived exosomes.
Liao X; Luo Y; Gu F; Song W; Nie X; Yang Q
Hepatol Int; 2023 Dec; 17(6):1659-1671. PubMed ID: 37046114
[TBL] [Abstract][Full Text] [Related]
17. miR221 regulates TGF-β1-induced HSC activation through inhibiting autophagy by directly targeting LAMP2.
Cheng R; Xu H; Hong Y
Mol Med Rep; 2021 Nov; 24(5):. PubMed ID: 34498712
[TBL] [Abstract][Full Text] [Related]
18. 3D hESC exosomes enriched with miR-6766-3p ameliorates liver fibrosis by attenuating activated stellate cells through targeting the TGFβRII-SMADS pathway.
Wang N; Li X; Zhong Z; Qiu Y; Liu S; Wu H; Tang X; Chen C; Fu Y; Chen Q; Guo T; Li J; Zhang S; Zern MA; Ma K; Wang B; Ou Y; Gu W; Cao J; Chen H; Duan Y
J Nanobiotechnology; 2021 Dec; 19(1):437. PubMed ID: 34930304
[TBL] [Abstract][Full Text] [Related]
19. Extracellular vesicles-derived miR-150-5p secreted by adipose-derived mesenchymal stem cells inhibits CXCL1 expression to attenuate hepatic fibrosis.
Du Z; Wu T; Liu L; Luo B; Wei C
J Cell Mol Med; 2021 Jan; 25(2):701-715. PubMed ID: 33342075
[TBL] [Abstract][Full Text] [Related]
20. Exosomal MALAT1 derived from hepatic cells is involved in the activation of hepatic stellate cells via miRNA-26b in fibrosis induced by arsenite.
Dai X; Chen C; Xue J; Xiao T; Mostofa G; Wang D; Chen X; Xu H; Sun Q; Li J; Wei Y; Chen F; Quamruzzaman Q; Zhang A; Liu Q
Toxicol Lett; 2019 Nov; 316():73-84. PubMed ID: 31513886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
